loading
Precedente Chiudi:
$1.11
Aprire:
$1.14
Volume 24 ore:
1.09M
Relative Volume:
0.65
Capitalizzazione di mercato:
$29.93M
Reddito:
$16.77M
Utile/perdita netta:
$-11.87M
Rapporto P/E:
-2.3408
EPS:
-0.4742
Flusso di cassa netto:
$-5.90M
1 W Prestazione:
+10.45%
1M Prestazione:
+107.87%
6M Prestazione:
+170.73%
1 anno Prestazione:
+12.12%
Intervallo 1D:
Value
$1.05
$1.16
Intervallo di 1 settimana:
Value
$0.82
$1.16
Portata 52W:
Value
$0.30
$1.16

Immunoprecise Antibodies Ltd Stock (IPA) Company Profile

Name
Nome
Immunoprecise Antibodies Ltd
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
101
Name
Cinguettio
Name
Prossima data di guadagno
2024-09-16
Name
Ultimi documenti SEC
Name
IPA's Discussions on Twitter

Confronta IPA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
IPA
Immunoprecise Antibodies Ltd
1.11 29.93M 16.77M -11.87M -5.90M -0.4742
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-12-02 Iniziato H.C. Wainwright Buy
2021-10-25 Iniziato The Benchmark Company Buy

Immunoprecise Antibodies Ltd Borsa (IPA) Ultime notizie

pulisher
Jun 18, 2025

Market Recap: ImmunoPrecise Antibodies Ltd (IPA)’s Positive Momentum, Closing at 0.95 - DWinneX

Jun 18, 2025
pulisher
Jun 18, 2025

We're Keeping An Eye On ImmunoPrecise Antibodies' (NASDAQ:IPA) Cash Burn Rate - Yahoo Finance

Jun 18, 2025
pulisher
Jun 18, 2025

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Sees Large Growth in Short Interest - Defense World

Jun 18, 2025
pulisher
Jun 13, 2025

ImmunoPrecise stock rating reiterated at Buy by H.C. Wainwright - Investing.com India

Jun 13, 2025
pulisher
Jun 12, 2025

ImmunoPrecise Antibodies (IPA) Showcases Groundbreaking AI-Desig - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

AI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Esty, America's Car-Mart, ImmunoPrecise - TradingView

Jun 12, 2025
pulisher
Jun 12, 2025

ImmunoPrecise’s AI-Designed Peptides Surpass Semaglutide in Receptor Activation - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

ImmunoPrecise Antibodies Says AI-Designed GLP-1 Peptides Surpass Semaglutide In Receptor Activation - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

AI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass Semaglutide in Receptor Activation Studies - The Joplin Globe

Jun 12, 2025
pulisher
Jun 06, 2025

Immunoprecise Antibodies discovers highly conserved epitope across all four dengue virus serotypes - BioWorld MedTech

Jun 06, 2025
pulisher
Jun 06, 2025

ImmunoPrecise jumps on reported vaccine breakthrough - The Pharma Letter

Jun 06, 2025
pulisher
Jun 06, 2025

ImmunoPrecise Antibodies (OTCMKTS:IPATF) Trading Up 1.8% – Here’s What Happened - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

ImmunoPrecise identifies universal dengue vaccine target By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

ImmunoPrecise Antibodies (IPA) Makes Breakthrough in Dengue Vacc - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Immunoprecise Announces Ai-Driven Breakthrough In Universal Dengue Vaccine Discovery - marketscreener.com

Jun 05, 2025
pulisher
Jun 05, 2025

ImmunoPrecise Unveils AI-Driven Breakthrough in Dengue Vaccine Discovery - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

ImmunoPrecise identifies universal dengue vaccine target - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery | IPA Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery - Yahoo Finance

Jun 05, 2025
pulisher
May 24, 2025

ImmunoPrecise Antibodies (NASDAQ:IPA) Stock Rating Upgraded by Wall Street Zen - Defense World

May 24, 2025
pulisher
May 21, 2025

ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Eng - GuruFocus

May 21, 2025
pulisher
May 21, 2025

ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Engagement Efforts - Yahoo Finance

May 21, 2025
pulisher
May 20, 2025

ImmunoPrecise Antibodies (IPA) to Present at Maxim Group's 2025 Virtual Tech Conference | IPA Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ImmunoPrecise Antibodies to Present at Maxim Group’s 2025 Virtual Tech Conference - TipRanks

May 20, 2025
pulisher
May 20, 2025

AI Breakthrough: ImmunoPrecise CEO Reveals Next-Gen Biotherapeutics Strategy at Major Tech Conference - Stock Titan

May 20, 2025
pulisher
May 20, 2025

ImmunoPrecise Antibodies (IPA) to Present at Maxim Group’s 2025 Virtual Tech Conference - New Castle News

May 20, 2025
pulisher
May 20, 2025

What's Going on With Apple Stock? - The Globe and Mail

May 20, 2025
pulisher
May 12, 2025

ImmunoPrecise Antibodies (IPA) Showcases Breakthrough in Epitope Mapping | IPA Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

ImmunoPrecise Antibodies’ LENSai Platform Revolutionizes Epitope Mapping - TipRanks

May 12, 2025
pulisher
May 12, 2025

IPA's LENSai™ Platform Delivers X-Ray--Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed | IPA Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

IPA’s LENSai™ Platform Delivers X-Ray–Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed - Yahoo Finance

May 12, 2025
pulisher
May 04, 2025

ImmunoPrecise Antibodies Ltd.'s (NASDAQ:IPA) Shares Leap 28% Yet They're Still Not Telling The Full Story - simplywall.st

May 04, 2025
pulisher
Apr 28, 2025

ImmunoPrecise’s BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery - ACCESS Newswire

Apr 28, 2025
pulisher
Apr 25, 2025

How ImmunoPrecise Antibodies ($IPA) Uses AI to Transform Antibody-Based Drug Discovery - Podomatic

Apr 25, 2025
pulisher
Apr 24, 2025

IPAImmunoprecise Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025
pulisher
Apr 24, 2025

Views of Wall Street’s Leading Experts on ImmunoPrecise Antibodies Ltd - Sete News

Apr 24, 2025
pulisher
Apr 24, 2025

ImmunoPrecise Antibodies (OTCMKTS:IPATF) Trading Down 7% – Should You Sell? - Defense World

Apr 24, 2025
pulisher
Apr 23, 2025

What is going on with ImmunoPrecise Antibodies Ltd? Sentiment Analysis - uspostnews.com

Apr 23, 2025
pulisher
Apr 22, 2025

Will ImmunoPrecise Antibodies (NASDAQ:IPA) Spend Its Cash Wisely? - simplywall.st

Apr 22, 2025
pulisher
Apr 14, 2025

H.C. Wainwright sets $50 target for ImmunoPrecise stock - Investing.com Australia

Apr 14, 2025
pulisher
Apr 14, 2025

H.C. Wainwright sets $50 target for ImmunoPrecise stock By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

ImmunoPrecise Antibodies’ (IPA) “Buy” Rating Reiterated at HC Wainwright - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI- - GuruFocus

Apr 12, 2025
pulisher
Apr 11, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods - 01net

Apr 11, 2025
pulisher
Apr 11, 2025

ImmunoPrecise Antibodies Aligns with FDA’s Move to Non-Animal Testing - TipRanks

Apr 11, 2025
pulisher
Apr 11, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSaitm with FDA's Shift to Non-Animal Testing Methods - Lelezard

Apr 11, 2025
pulisher
Apr 11, 2025

AI Breakthrough: How IPA's LENSai Platform Leads FDA's Historic Shift from Animal Testing - Stock Titan

Apr 11, 2025
pulisher
Apr 10, 2025

ImmunoPrecise Antibodies Partners with RIBOPRO to Enhance Antibody Discovery - TipRanks

Apr 10, 2025

Immunoprecise Antibodies Ltd Azioni (IPA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Capitalizzazione:     |  Volume (24 ore):